Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6391]

A bacterial toxin can counteract colorectal cancer growth

A bacterial toxin can counteract colorectal cancer growth

What is the ideal duration of hormone therapy for the treatment of prostate cancer?

What is the ideal duration of hormone therapy for the treatment of prostate cancer?

Blocking a cancer-related pathway helps reduce spine deformities due to genetic disorder, finds new study

Blocking a cancer-related pathway helps reduce spine deformities due to genetic disorder, finds new study

Less survivable cancers receive just 19% of research funding despite causing 40% of all cancer deaths in the UK

Less survivable cancers receive just 19% of research funding despite causing 40% of all cancer deaths in the UK

Blood test predicts which patients with lung cancer will benefit from newly approved immunotherapy drug

Blood test predicts which patients with lung cancer will benefit from newly approved immunotherapy drug

Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy

Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy

Therapies that target specific type of cell death may be an effective avenue for cancer treatment

Therapies that target specific type of cell death may be an effective avenue for cancer treatment

Study: ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care

Study: ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care

Inflammatory immune cells predict survival, relapse in multiple myeloma

Inflammatory immune cells predict survival, relapse in multiple myeloma

Researchers uncover how tumours become resistant to promising p53-targeted therapy

Researchers uncover how tumours become resistant to promising p53-targeted therapy

More from ecancer